Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WBI-1001 Cream in Atopic Dermatitis
NCT01098734Phase 2Completed
- Sponsor
- Welichem Biotech
- Start
- Nov 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tapinarof in atopic dermatitis (AD), sponsored by Welichem Biotech. Started Nov 2009; status: completed.
02
Drugs
tapinarof
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01098734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01098734.